title: Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families.
abstract: Many rearrangement mutations in the BRCA1 gene have been identified. It is becoming clear that some of these mutations are prevalent, and therefore their detection is necessary in order for clinical genetic tests to have high sensitivity. Published information on particular rearrangements is frequently limited to a single patient, small groups of patients, or patients of a particular ethnicity. The objectives of this work included characterizing the prevalence of five specific rearrangement mutations in a large North American patient population. A mutation-specific multiplex PCR assay was used for determining the prevalence of five BRCA1 rearrangement mutations that previously had been reported to occur in unrelated patients. The mutation status of these rearrangements, which came from 20,712 patients at high risk for hereditary breast and/or ovarian cancers who had submitted specimens for clinical genetic testing, is presented. The results, obtained from 2,634 mutation carriers, showed a 6-kb duplication of exon 13, identified in 53 patients (2.01%); a 26-kb deletion encompassing exons 14-20, detected in seven patients (0.27%); a 510-bp deletion of exon 22, detected in 5 patients (0.19%); and a 3.4-kb deletion of exon 13, detected in one patient (0.04%). A previously reported 7.1-kb deletion of exons 8-9 was not found. The high frequency of the exon 13 duplication makes it the fourth most prevalent mutation in these patients. These results provide an accurate picture of the prevalence of these mutations in hereditary breast/ovarian cancer patients undergoing genetic testing in North America.
authors.affiliation: Myriad Genetic Laboratories, Inc., Salt Lake City, UT 84108.
authors.forename: Brant C
authors.initials: BC
authors.lastname: Hendrickson
authors.forename: Thaddeus
authors.initials: T
authors.lastname: Judkins
authors.forename: Benjamin D
authors.initials: BD
authors.lastname: Ward
authors.forename: Kristilyn
authors.initials: K
authors.lastname: Eliason
authors.forename: Amie E
authors.initials: AE
authors.lastname: Deffenbaugh
authors.forename: Lynn Anne
authors.initials: LA
authors.lastname: Burbidge
authors.forename: Kristin
authors.initials: K
authors.lastname: Pyne
authors.forename: Benoît
authors.initials: B
authors.lastname: Leclair
authors.forename: Brian E
authors.initials: BE
authors.lastname: Ward
authors.forename: Thomas
authors.initials: T
authors.lastname: Scholl
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics*; D005006:Ethnicity / Q000235:genetics; D005091:Exons; D005260:Female; D005784:Gene Amplification; D015321:Gene Rearrangement; D019398:Genes, BRCA1; D006801:Humans; D009154:Mutation; D010051:Ovarian Neoplasms / Q000235:genetics*; D044469:Racial Groups / Q000235:genetics; D012016:Reference Values; D017384:Sequence Deletion